Multi-Institution Evaluation of Sequential Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guerin Naïve Patients with Non-Muscle Invasive Bladder Cancer

Lewis J. Thomas,Ryan L. Steinberg,Vignesh T. Packiam,Ian M. McElree,Nathan Brooks,Andrew Vitale,Eric Hyndman,Trafford Crump,Mounica Y. Rao,Donald L. Lamm,Marcus J. Daniels,Max Kates,Supriya Nagaraju,Ashish M. Kamat,Trinity J. Bivalacqua,Sarah L. Mott,Kenneth G. Nepple,Michael A. O'Donnell

Clinical Genitourinary Cancer（2022）

Cited 0|Views7

No score

Abstract

•Due to production shortages, BCG has been precluded from many urological practices.•Gem/Doce is a safe and effective treatment for NMIBC.•Further prospective evaluation is underway.

Translated text

Key words

Urinary Bladder Neoplasms,Chemotherapy, Adjuvant,Gemcitabine,Docetaxel

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined